Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Role of thrombophilia in deciding on the duration of anticoagulation.

Seminars in thrombosis and hemostasis - 1 Dec 2004

Bauer Kenneth A

Abstract excerpt

It is now possible to identify hereditary risk factors in a substantial percentage of patients presenting with a venous thrombotic event. Discovery of the factor V Leiden and prothrombin G20210A mutations has greatly increased the percentage of patients in whom venous thrombosis can be attributed to hereditary thrombophilia. There is considerable uncertainty, however, as to how this information should be used in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Prothrombin
Share to Anticoagulants
Share to International Normalized Ratio

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Thromboembolism

Share to Thrombophilia

Share to Venous Thrombosis

Share to Vitamin K

Share to Warfarin

Source

Identifiers

PMID: 15630669
DOI: 10.1055/s-2004-861505

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Role of thrombophilia in deciding on the duration of anticoagulation.PMID 15630669Read ↗

Management of thrombophilia.Semantic proximity Read ↗

Anticoagulation duration in heterozygous factor V Leiden: a decision analysis.Semantic proximity Read ↗

How to decide on the optimal duration of anticoagulatn therapy in carriers of the factor V Leiden mutation.Semantic proximity Read ↗

Duration of anticoagulant treatment for venous thrombosis.Semantic proximity Read ↗

Optimal duration of anticoagulation. Provoked versus unprovoked VTE and role of adjunctive thrombophilia and imaging tests.Semantic proximity Read ↗

Influence of thrombophilia on risk of recurrent venous thromboembolism while on warfarin: results from a randomized trial.Semantic proximity Read ↗

Aspects of the clinical management of hereditary thrombophilia: a personal perspective.Semantic proximity Read ↗

The risk of early recurrent venous thromboembolism after oral anticoagulant therapy in patients with the G20210A transition in the prothrombin gene.Semantic proximity Read ↗

Appraisal of current vitamin K dosing algorithms for the reversal of over-anticoagulation with warfarin: the need for a more tailored dosing regimen.Semantic proximity Read ↗

Long-term, low-dose warfarin among venous thrombosis patients with and without factor V Leiden mutation: rationale and design for the Prevention of Recurrent Venous Thromboembolism (PREVENT) trial.Semantic proximity Read ↗

Decision analysis model of prolonged oral anticoagulant treatment in factor V Leiden carriers with first episode of deep vein thrombosis.Semantic proximity Read ↗

Predictors of the post-thrombotic syndrome during long-term treatment of proximal deep vein thrombosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.